Conduit Pharmaceuticals Inc (NASDAQ: CDT) is -89.47% lower on its value in year-to-date trading and has touched a low of $0.73 and a high of $379.00 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The CDT stock was last observed hovering at around $0.78 in the last trading session, with the day’s loss setting it -0.06%.
Currently trading at $0.72, the stock is -24.27% and -58.84% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 3.24 million and changing -7.54% at the moment leaves the stock -96.20% off its SMA200. CDT registered -99.80% loss for a year compared to 6-month loss of -94.24%. The firm has a 50-day simple moving average (SMA 50) of $1.756 and a 200-day simple moving average (SMA200) of $19.01.
The stock witnessed a -37.75% gain in the last 1 month and extending the period to 3 months gives it a -87.99%, and is -12.09% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 25.13% over the week and 14.50% over the month.
Conduit Pharmaceuticals Inc (CDT) has around 6 employees, a market worth around $4.81M and $0.00M in sales. Distance from 52-week low is -0.40% and -99.81% from its 52-week high.
.
Conduit Pharmaceuticals Inc (CDT) Top Institutional Holders
57.0 institutions hold shares in Conduit Pharmaceuticals Inc (CDT), with institutional investors hold 1.42% of the company’s shares. The shares outstanding are 4.71M, and float is at 4.25M with Short Float at 17.68%. Institutions hold 1.32% of the Float.
The top institutional shareholder in the company is BLACKROCK INC. with over 0.69 million shares valued at $0.73 million. The investor’s holdings represent 0.0187% of the CDT Shares outstanding. As of 2024-06-30, the second largest holder is NEW YORK STATE COMMON RETIREMENT FUND with 98100.0 shares valued at $0.1 million to account for 0.0027 of the shares outstanding. The other top investors are MARSHALL WACE, LLP which holds 59728.0 shares representing 0.0016% and valued at over $63312.0, while MORGAN STANLEY holds 0.0015 of the shares totaling 56731.0 with a market value of $60135.0.
Conduit Pharmaceuticals Inc (CDT) Insider Activity
The most recent transaction is an insider sale by Nirland Ltd, the company’s 10% Owner. SEC filings show that Nirland Ltd sold 1,500,000 shares of the company’s common stock on Oct 03 ’24 at a price of $0.10 per share for a total of $0.16 million. Following the sale, the insider now owns 8.4 million shares.
Conduit Pharmaceuticals Inc disclosed in a document filed with the SEC on Oct 04 ’24 that Nirland Ltd (10% Owner) sold a total of 1,368,991 shares of the company’s common stock. The trade occurred on Oct 04 ’24 and was made at $0.10 per share for $0.14 million. Following the transaction, the insider now directly holds 7.03 million shares of the CDT stock.
Still, SEC filings show that on Oct 07 ’24, Nirland Ltd (10% Owner) disposed off 939,009 shares at an average price of $0.10 for $96530.0. The insider now directly holds 6,092,000 shares of Conduit Pharmaceuticals Inc (CDT).
